1. Home
  2. SYBX vs MXC Comparison

SYBX vs MXC Comparison

Compare SYBX & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • MXC
  • Stock Information
  • Founded
  • SYBX N/A
  • MXC 1972
  • Country
  • SYBX United States
  • MXC United States
  • Employees
  • SYBX N/A
  • MXC N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • SYBX Health Care
  • MXC Energy
  • Exchange
  • SYBX Nasdaq
  • MXC Nasdaq
  • Market Cap
  • SYBX 16.4M
  • MXC 17.6M
  • IPO Year
  • SYBX N/A
  • MXC N/A
  • Fundamental
  • Price
  • SYBX $1.59
  • MXC $8.35
  • Analyst Decision
  • SYBX
  • MXC
  • Analyst Count
  • SYBX 0
  • MXC 0
  • Target Price
  • SYBX N/A
  • MXC N/A
  • AVG Volume (30 Days)
  • SYBX 19.9K
  • MXC 3.0K
  • Earning Date
  • SYBX 11-11-2025
  • MXC 11-06-2025
  • Dividend Yield
  • SYBX N/A
  • MXC 1.20%
  • EPS Growth
  • SYBX N/A
  • MXC 44.21
  • EPS
  • SYBX N/A
  • MXC 0.79
  • Revenue
  • SYBX N/A
  • MXC $7,444,407.00
  • Revenue This Year
  • SYBX N/A
  • MXC N/A
  • Revenue Next Year
  • SYBX N/A
  • MXC N/A
  • P/E Ratio
  • SYBX N/A
  • MXC $10.54
  • Revenue Growth
  • SYBX N/A
  • MXC 13.06
  • 52 Week Low
  • SYBX $0.90
  • MXC $5.89
  • 52 Week High
  • SYBX $1.96
  • MXC $16.00
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 64.64
  • MXC 49.91
  • Support Level
  • SYBX $1.45
  • MXC $8.30
  • Resistance Level
  • SYBX $1.54
  • MXC $8.82
  • Average True Range (ATR)
  • SYBX 0.06
  • MXC 0.26
  • MACD
  • SYBX 0.01
  • MXC 0.03
  • Stochastic Oscillator
  • SYBX 94.74
  • MXC 41.24

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: